EarningsQ3 2024 Earnings Report

Relmada Therapeutics (4E2) Q3 2024 Earnings Report

0 Followers

DE:4E2 Q3 2024 EPS Results

Actual EPS-€0.62

Consensus EPS-€0.59

Beat/MissMissed by -€0.04

One Year Ago EPS-€0.63

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ3 2024

Date11/07/2024

TimeAfter Close

Conference CallThursday, November 7, 2024

DE:4E2 Upcoming Earnings

Relmada Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:4E2 Q3 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.13 / -	-0.26	―
Aug 06, 2026	2026 (Q2)	-0.17 / -0.10	-0.26	63.33% (+0.16)
May 12, 2026	2026 (Q1)	-0.17 / -0.19	-0.503	62.07% (+0.31)
Mar 19, 2026	2025 (Q4)	-0.13 / -0.23	-0.538	56.45% (+0.30)
Nov 13, 2025	2025 (Q3)	-0.37 / -0.26	-0.624	58.33% (+0.36)
Aug 07, 2025	2025 (Q2)	-0.40 / -0.26	-0.512	49.15% (+0.25)
May 12, 2025	2025 (Q1)	-0.42 / -0.50	-0.624	19.44% (+0.12)
Mar 27, 2025	2024 (Q4)	-0.58 / -0.54	-0.728	26.19% (+0.19)
Nov 07, 2024	2024 (Q3)	-0.59 / -0.62	-0.633	1.37% (<+0.01)
Aug 07, 2024	2024 (Q2)	-0.72 / -0.51	-0.728	29.76% (+0.22)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed